A Phase Ib, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Coagulation Factor VIIa in Congenital Hemophilia A or B

The requested reference [50ebaf8e9788e3c1bb408b3746aafa6d450d3be8] no longer exists in our database. It has been replaced by the current reference: [919340859a39618f840c7d000f4dd805c1ec0df0]

Authors
Category Primary study
ConferenceHaemophilia
Year 2016
This article has no abstract
Epistemonikos ID: b2749ce326ae02272175c730ab3fad1cf9fcfe83
First added on: Apr 29, 2026